GSK files Nucala for COPD
admin 8th November 2017 Uncategorised 0GlaxoSmithKline is seeking permission to market its asthma biologic mepolizumab for the treatment of eosinophilic chronic obstructive pulmonary disease (COPD) in the US.
More: GSK files Nucala for COPD
Source: News